Pharming Group N.V. PHGUF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 9.30M | 12.36M | 2.85M | 382.00K | -8.20M |
| Total Depreciation and Amortization | 11.01M | 10.86M | 10.32M | 9.83M | 9.85M |
| Total Amortization of Deferred Charges | 893.00K | 893.00K | 893.00K | 852.00K | 852.00K |
| Total Other Non-Cash Items | 17.42M | 22.91M | 30.26M | 38.28M | 32.00M |
| Change in Net Operating Assets | -3.60M | 9.41M | 10.39M | 3.99M | -3.45M |
| Cash from Operations | 35.03M | 56.43M | 54.71M | 53.33M | 31.05M |
| Capital Expenditure | -660.00K | -705.00K | -749.00K | -610.00K | -906.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 0.00 | 0.00 | -57.48M | -57.48M | -57.48M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -84.58M | -67.49M | 84.48M | 74.59M | 79.59M |
| Cash from Investing | -85.24M | -68.20M | 26.25M | 16.51M | 21.21M |
| Total Debt Issued | -- | -- | -- | 0.00 | -263.00K |
| Total Debt Repaid | -16.36M | -16.51M | -4.25M | -4.39M | -4.28M |
| Issuance of Common Stock | 23.62M | 23.45M | 19.81M | 16.66M | 3.40M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -7.96M | -7.95M | -14.07M | -14.01M | -11.98M |
| Cash from Financing | -697.00K | -1.01M | 1.50M | -1.75M | -13.11M |
| Foreign Exchange rate Adjustments | -698.00K | 5.07M | 7.91M | 3.62M | 5.81M |
| Miscellaneous Cash Flow Adjustments | 117.80M | -2.00K | -1.00K | -1.00K | -- |
| Net Change in Cash | 66.19M | -7.71M | 90.36M | 71.71M | 44.95M |